NeuroStar Advanced Therapy for Mental Health Recognized as Top Neuromodulation Solution Provider in 2021
10 janv. 2022 08h31 HE
|
Neuronetics
MALVERN, Pa., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces 510(k) Clearance of MT Cap Technology for NeuroStar® Advanced Therapy for Mental Health
20 déc. 2021 08h31 HE
|
Neuronetics
MALVERN, Pa., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Announces Key Role for NeuroStar Advanced Therapy at 4th International Brain Stimulation Conference
06 déc. 2021 08h31 HE
|
Neuronetics
MALVERN, Pa., Dec. 06, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics and River Region Psychiatry Announce Exclusive Partnership
08 nov. 2021 10h00 HE
|
Neuronetics
Partnership Will Bring Non-drug NeuroStar® Advanced Therapy For Mental Health To Thousands of Patients Across the Southeast MALVERN, Pa., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc....
Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
26 oct. 2021 08h30 HE
|
Neuronetics
MALVERN, Pa., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve...
Neuronetics Launches Upgrades of NeuroStar® Advanced Therapy for Mental Health
19 oct. 2021 08h31 HE
|
Neuronetics
System Innovations Improve Efficiencies for Healthcare Practices and Patients MALVERN, Pa., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology...
NeuroStar® Advanced Therapy Recognizes National Depression Education and Awareness Month With New Campaign Launch
04 oct. 2021 08h40 HE
|
Neuronetics
MALVERN, Pa., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
UPDATE - New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS
22 sept. 2021 18h33 HE
|
Neuronetics
MALVERN, Pa., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
New Data Highlights NeuroStar® Advanced Therapy for Mental Health Safety Over H-Coil TMS
21 sept. 2021 08h30 HE
|
Neuronetics
MALVERN, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...
Neuronetics and Zion Healing Announce First Franchise Model for TMS Clinics
07 sept. 2021 08h30 HE
|
Neuronetics
MALVERN, Pa. and ST. GEORGE, Utah, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing...